Treatments for Medulloblastoma in Children
Researchers based at the Children’s National Research Institute, Washington, DC have identified unique proteins in a patient’s individual tumour cells, allowing them to generate personalised T cells to target and kill tumours. This is reportedly the first effort to create a new workflow for neoantigen identification that incorporates both genetic sequencing and protein identification to create a personalised treatment for medulloblastoma in children. Given these findings, the researchers...
Comments
Post a Comment